Dr. Rashad Belin, MD (he/him) is a Cardiologist, Interventional Cardiologist, Internist in Chicago, IL with over 13 years of experience. What is your opinion of Dr. Rashad Belin, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 13 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Rashad Belin, MD has received over $9,470 which includes payments from the following companies:
$6,835.48 from Medtronic Vascular, Inc.
$781.05 from Cardiovascular Systems Inc.
$298.69 from Janssen Pharmaceuticals, Inc
$216.09 from Abbott Laboratories
$179.28 from Philips Electronics North America Corporation
$168.21 from Novartis Pharmaceuticals Corporation
$132.95 from Amgen Inc.
$125.92 from Boston Scientific Corporation
$124.97 from CARDIVA MEDICAL, INC.
$89.41 from Pfizer Inc.
$89.31 from Edwards Lifesciences Corporation
$76.97 from Regeneron Healthcare Solutions, Inc.
$62.01 from Merck Sharp & Dohme Corporation
$59.65 from ABIOMED
$51.33 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$40.08 from DePuy Orthopaedics Inc.
$30.14 from Alnylam Pharmaceuticals Inc.
$25.74 from AstraZeneca Pharmaceuticals LP
$24.37 from Amarin Pharma Inc.
$17.13 from Cardinal Health 200, LLC
Payments received by Dr. Rashad Belin, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!